Alligator Bioscience Presents Positive Biomarker Data for Mitazalimab in Pancreatic Cancer at ASCO 2025

Alligator Bioscience announced the presentation of biomarker data from its OPTIMIZE-1 clinical trial at the 2025 ASCO Annual Meeting. OPTIMIZE-1 is a ...
Home/KnloSights/Clinical Trial Updates/Alligator Bioscience Presents Positive Biomarker Data for Mitazalimab in Pancreatic Cancer at ASCO 2025